PT2184279E - Composição farmacêutica contendo um composto oticamente ativo com atividade de agonista do recetor da trombopoietina e seu intermediário - Google Patents
Composição farmacêutica contendo um composto oticamente ativo com atividade de agonista do recetor da trombopoietina e seu intermediário Download PDFInfo
- Publication number
- PT2184279E PT2184279E PT87917761T PT08791776T PT2184279E PT 2184279 E PT2184279 E PT 2184279E PT 87917761 T PT87917761 T PT 87917761T PT 08791776 T PT08791776 T PT 08791776T PT 2184279 E PT2184279 E PT 2184279E
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical composition
- composition containing
- active compound
- optically active
- receptor agonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007198590 | 2007-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2184279E true PT2184279E (pt) | 2015-02-05 |
Family
ID=40304328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT87917761T PT2184279E (pt) | 2007-07-31 | 2008-07-29 | Composição farmacêutica contendo um composto oticamente ativo com atividade de agonista do recetor da trombopoietina e seu intermediário |
Country Status (21)
Country | Link |
---|---|
US (2) | US8530668B2 (pt) |
EP (1) | EP2184279B1 (pt) |
JP (1) | JP5164181B2 (pt) |
KR (1) | KR20100027243A (pt) |
CN (4) | CN103396313B (pt) |
AU (1) | AU2008283357B2 (pt) |
BR (1) | BRPI0814891A2 (pt) |
CA (1) | CA2694567C (pt) |
CY (1) | CY1116190T1 (pt) |
DK (1) | DK2184279T3 (pt) |
ES (1) | ES2528196T3 (pt) |
FR (1) | FR19C1043I2 (pt) |
HR (1) | HRP20150062T1 (pt) |
MX (1) | MX2010001082A (pt) |
NL (1) | NL300998I2 (pt) |
PL (1) | PL2184279T3 (pt) |
PT (1) | PT2184279E (pt) |
RU (1) | RU2476429C2 (pt) |
SI (1) | SI2184279T1 (pt) |
TW (1) | TWI422371B (pt) |
WO (1) | WO2009017098A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI564008B (zh) * | 2010-09-30 | 2017-01-01 | 鹽野義製藥股份有限公司 | 難溶性藥物之溶解性改善製劑 |
JP6202620B2 (ja) * | 2012-06-29 | 2017-09-27 | 塩野義製薬株式会社 | トロンボポエチン受容体アゴニスト作用を有する化合物を含有する医薬組成物 |
US20140047572A1 (en) * | 2012-08-13 | 2014-02-13 | University Of Rochester | Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury |
CN105992761A (zh) * | 2013-12-20 | 2016-10-05 | 盐野义制药株式会社 | 具有血小板生成素受体激动作用的光学活性的化合物及其中间体的制备方法 |
CN105412930A (zh) * | 2015-08-07 | 2016-03-23 | 军事医学科学院华南干细胞与再生医学研究中心 | 血小板生成素受体激动剂在促进造血干细胞归巢中的用途 |
JP6168579B1 (ja) * | 2016-02-12 | 2017-07-26 | 塩野義製薬株式会社 | 重度の肝機能障害のある患者のためのルストロンボパグを含有する血小板産生促進剤 |
CN106083759B (zh) * | 2016-06-15 | 2022-02-15 | 上海丸全化学科技有限公司 | 一种芦曲泊帕的全新合成工艺 |
CN109415371B (zh) * | 2016-09-08 | 2021-07-09 | 四川科伦博泰生物医药股份有限公司 | 一种2-酰氨基噻唑衍生物及其制备方法与用途 |
CN106565625B (zh) * | 2016-11-04 | 2018-01-30 | 杭州励德生物科技有限公司 | 一种抗血小板减少症新药Lusutrombopag中间体的制备方法 |
WO2018149309A1 (zh) * | 2017-02-14 | 2018-08-23 | 四川科伦药物研究院有限公司 | 4-苯基噻唑衍生物的晶型及其制备方法 |
CN109970678B (zh) * | 2017-12-28 | 2024-03-08 | 四川科伦药物研究院有限公司 | 4-苯基噻唑衍生物无定形及其制备方法和用途 |
ES2953320T3 (es) * | 2018-06-08 | 2023-11-10 | Sichuan Kelun Pharm Res Inst Co Ltd | Forma Cristalina de derivado de 4-feniltiazol y método de preparación de la misma |
CN113164455A (zh) * | 2018-12-04 | 2021-07-23 | 盐野义制药株式会社 | 难溶性药物的固体分散体 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9608587A (pt) * | 1995-06-07 | 1999-01-05 | Glaxo Group Ltd | Composto que se liga ao receptor de trombopoietina composição farmacêutica e processo para o tratamento de um paciente sofrendo de um distúrbio |
JPH1072492A (ja) | 1996-09-02 | 1998-03-17 | Hokuriku Seiyaku Co Ltd | ペプチド化合物 |
JPH10287634A (ja) | 1997-04-11 | 1998-10-27 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体 |
JPH111477A (ja) | 1997-06-12 | 1999-01-06 | Hokuriku Seiyaku Co Ltd | 1,4−ベンゾジアゼピン誘導体及びその用途 |
JPH11152276A (ja) | 1997-11-20 | 1999-06-08 | Hokuriku Seiyaku Co Ltd | ベンゾジアゼピン誘導体 |
GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
GC0000177A (en) | 1998-12-17 | 2006-03-29 | Smithkline Beecham | Thrombopoietin mimetics |
CN1376150A (zh) | 1999-07-26 | 2002-10-23 | 盐野义制药株式会社 | 具有血栓形成素受体拮抗作用的药物组合物 |
TWI284639B (en) | 2000-01-24 | 2007-08-01 | Shionogi & Co | A compound having thrombopoietin receptor agonistic effect |
EP1354880A4 (en) | 2001-01-26 | 2004-08-25 | Shionogi & Co | HALOGEN COMPOUNDS HAVING AGONISM TOWARDS THROMBOPOIETIN RECEPTOR |
WO2002059099A1 (fr) | 2001-01-26 | 2002-08-01 | Shionogi & Co., Ltd. | Composes cycliques presentant un agonisme envers le recepteur de thrombopoietine |
EP1357116A4 (en) | 2001-02-02 | 2005-06-01 | Yamanouchi Pharma Co Ltd | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF |
JP4120586B2 (ja) | 2002-01-18 | 2008-07-16 | アステラス製薬株式会社 | 2−アシルアミノチアゾール誘導体又はその塩 |
JP4317818B2 (ja) | 2002-09-30 | 2009-08-19 | アステラス製薬株式会社 | 2−アシルアミノチアゾール誘導体の新規な塩 |
US6737382B1 (en) * | 2002-10-23 | 2004-05-18 | Nippon Soda Co. Ltd. | Insecticidal aminothiazole derivatives |
FR2854158B1 (fr) * | 2003-04-25 | 2006-11-17 | Sanofi Synthelabo | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique |
US7361658B2 (en) | 2003-07-17 | 2008-04-22 | Astellas Pharma Inc. | 2-acylaminothiazole derivative or salt thereof |
KR100776961B1 (ko) * | 2003-08-12 | 2007-11-28 | 시오노기세이야쿠가부시키가이샤 | 트롬보포이에틴 수용체 아고니스트 작용을 가지는 화합물 |
WO2005026137A2 (en) * | 2003-09-06 | 2005-03-24 | Vertex Pharmaceuticals Incorporated | Modulators of atp-binding cassette transporters |
JP4665769B2 (ja) | 2005-01-12 | 2011-04-06 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体の製造法 |
JP4774995B2 (ja) | 2005-01-12 | 2011-09-21 | アステラス製薬株式会社 | アシルアミノチアゾール誘導体を有効成分とする医薬組成物 |
WO2007004038A1 (en) | 2005-07-05 | 2007-01-11 | Pfizer Products Inc. | Aminothiazole derivatives as agonists of the thrombopoietin receptor |
US8515798B2 (en) | 2005-09-27 | 2013-08-20 | Accenture Global Services Gmbh | Closed-loop supply chain in the paper packaging sector |
KR20080074166A (ko) | 2005-11-08 | 2008-08-12 | 아스테라스 세이야쿠 가부시키가이샤 | 혈소판감소증을 치료하는 조성물 및 방법 |
-
2008
- 2008-07-29 PL PL08791776T patent/PL2184279T3/pl unknown
- 2008-07-29 ES ES08791776.1T patent/ES2528196T3/es active Active
- 2008-07-29 CA CA2694567A patent/CA2694567C/en active Active
- 2008-07-29 WO PCT/JP2008/063541 patent/WO2009017098A1/ja active Application Filing
- 2008-07-29 CN CN201310356204.4A patent/CN103396313B/zh active Active
- 2008-07-29 EP EP08791776.1A patent/EP2184279B1/en active Active
- 2008-07-29 DK DK08791776.1T patent/DK2184279T3/en active
- 2008-07-29 BR BRPI0814891-0A patent/BRPI0814891A2/pt not_active IP Right Cessation
- 2008-07-29 CN CN201310356507.6A patent/CN103450110B/zh active Active
- 2008-07-29 KR KR1020107002144A patent/KR20100027243A/ko active Search and Examination
- 2008-07-29 AU AU2008283357A patent/AU2008283357B2/en active Active
- 2008-07-29 SI SI200831361T patent/SI2184279T1/sl unknown
- 2008-07-29 MX MX2010001082A patent/MX2010001082A/es active IP Right Grant
- 2008-07-29 CN CN2013103563691A patent/CN103393678A/zh active Pending
- 2008-07-29 US US12/671,476 patent/US8530668B2/en active Active
- 2008-07-29 CN CN2008801104301A patent/CN101809008B/zh active Active
- 2008-07-29 RU RU2010107169/04A patent/RU2476429C2/ru active
- 2008-07-29 PT PT87917761T patent/PT2184279E/pt unknown
- 2008-07-29 JP JP2009525398A patent/JP5164181B2/ja active Active
- 2008-07-30 TW TW097128751A patent/TWI422371B/zh active
-
2013
- 2013-02-13 US US13/766,752 patent/US8889722B2/en active Active
-
2015
- 2015-01-19 HR HRP20150062AT patent/HRP20150062T1/hr unknown
- 2015-01-21 CY CY20151100059T patent/CY1116190T1/el unknown
-
2019
- 2019-06-27 NL NL300998C patent/NL300998I2/nl unknown
- 2019-06-28 FR FR19C1043C patent/FR19C1043I2/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2184279A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN OPTICALLY ACTIVE COMPOUND WITH THROMBOPOIETIN RECEPTOR AGONIST EFFECT AND INTERMEDIATE PRODUCT THEREOF | |
EP2130552A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE | |
EP2078731A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT | |
EP2172223A4 (en) | COMPOSITION CONTAINING A PHYSIOLOGICALLY ACTIVE SUBSTANCE | |
ZA200801275B (en) | Pharmaceutical preparation containing meloxicam | |
IL210195A (en) | Benzoxazines, benzazazines, and related compounds with nos inhibitory activity, medicinal preparations and their use | |
ZA200808530B (en) | Pharmaceutical composition for external use | |
ZA200808531B (en) | Pharmaceutical composition for external use | |
EP2183213A4 (en) | OPTICALLY ACTIVE (R) -ARYLOXYPROPIONIC ACID AMIDE AND HERBICIDES COMPOSITION CONTAINING THEREOF | |
EP2081550A4 (en) | COATING CAPSULES WITH ACTIVE PHARMACEUTICAL INGREDIENTS | |
BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
EP2040721A4 (en) | HONEY CONTAINING MEDICAL COMPOSITIONS | |
AP2975A (en) | Pharmaceutical formulations containing dopamine receptor ligands | |
IL204942A0 (en) | Heterocyclic compound and pharmaceutical composition thereof | |
ZA200808162B (en) | Active ingredient combinations with insecticidal properties | |
AP2920A (en) | Anti-malarial pharmaceutical composition | |
EP2062579A4 (en) | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING OPTICALLY STABLE RAMOSETRON | |
EP2468771A4 (en) | PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE | |
DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
IL209698A (en) | Use of Niportimox for the preparation of pharmaceuticals and preparations containing this Niportimox | |
EP2006287A4 (en) | COMPOUND HAVING ANTIMALARIAL ACTIVITY AND ANTIMALARIAL DRUG CONTAINING IT AS AN ACTIVE SUBSTANCE | |
EP2320879A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISES JASMONATES | |
BRPI0923763A2 (pt) | composto, utilização de um composto e composição farmacêutica | |
BRPI0810057A2 (pt) | Composição farmacêutica contendo floroglucinol e paracetamol |